JOIN US to review the National Eye Institute's latest scientific evidence, and hear ophthalmic and optometric perspectives on the meaning behind these results. This webinar will discuss the AREDS2 10 year follow-on study, its impact on patients with moderate-to-advanced AMD and the strategies that can be implemented to improve patient care.

Tuesday, October 18
8:00-9:00pm ET


Paul Karpecki, O.D., FAAO


Clinical Director at Kentucky Eye Institute

Rishi P. Singh, M.D.


Staff Physician, Cleveland Clinic
President of Cleveland Clinic
Martin Hospitals

Jeffry Gerson, O.D., FA AO


Medical Director at Grin Eye Care
 Leawood, KS

Emily Chew, M.D


Chair of AREDS2 Study, NEI






No CE/CME will be provided for this event.

AREDS2 is a registered trademark of the United States Department of Health and Human Services (HHS).
© 2022 Bausch + Lomb Incorporated or its affiliates.